BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 31220315)

  • 1. Increased expression of Fas on group 2 and 3 innate lymphoid cells is associated with an interferon signature in systemic lupus erythematosus and Sjögren's syndrome.
    Blokland SLM; van den Hoogen LL; Leijten EFA; Hartgring SAY; Fritsch R; Kruize AA; van Roon JAG; Radstake TRDJ
    Rheumatology (Oxford); 2019 Oct; 58(10):1740-1745. PubMed ID: 31220315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a Novel Serum Proteomic Signature for Primary Sjögren's Syndrome.
    Padern G; Duflos C; Ferreira R; Assou S; Guilpain P; Maria ATJ; Goulabchand R; Galea P; Jurtela M; Jorgensen C; Pers YM
    Front Immunol; 2021; 12():631539. PubMed ID: 33708222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PANoptosis Features, a Humanized NSG Murine Model of Sjogren's Syndrome.
    Yang Y; Zhang H; Xiao X; Guo M
    DNA Cell Biol; 2024 May; 43(5):207-218. PubMed ID: 38635961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome.
    Gottenberg JE; Cagnard N; Lucchesi C; Letourneur F; Mistou S; Lazure T; Jacques S; Ba N; Ittah M; Lepajolec C; Labetoulle M; Ardizzone M; Sibilia J; Fournier C; Chiocchia G; Mariette X
    Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2770-5. PubMed ID: 16477017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the shared molecular mechanisms between systemic lupus erythematosus and primary Sjögren's syndrome based on integrated bioinformatics and single-cell RNA-seq analysis.
    Cui Y; Zhang H; Wang Z; Gong B; Al-Ward H; Deng Y; Fan O; Wang J; Zhu W; Sun YE
    Front Immunol; 2023; 14():1212330. PubMed ID: 37614232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compositional and functional aberrance of the gut microbiota in treatment-naïve patients with primary Sjögren's syndrome.
    Jia XM; Wu BX; Chen BD; Li KT; Liu YD; Xu Y; Wang J; Zhang X
    J Autoimmun; 2023 Dec; 141():103050. PubMed ID: 37120327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of innate lymphoid cells in systemic lupus erythematosus.
    Chen Y; Gu X; Cao K; Tu M; Liu W; Ju J
    Cytokine; 2024 Jul; 179():156623. PubMed ID: 38685155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-Depth Proteomic Map of Innate Lymphoid Cells from Healthy Human Skin and Blood.
    Teunissen MBM; Pilgaard Møller LB; Løvendorf MB; Skov L; Bonefeld CM; Bekkenk MW; Clark RA; Mann M; Dyring-Andersen B
    J Invest Dermatol; 2024 Feb; 144(2):316-330.e3. PubMed ID: 37544588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The enrichment of Arg1
    Lu Z; Wang H; Gong Z; Guo P; Li C; Bi K; Li X; Chen Y; Pan A; Xu Y; Zhou P; Wei Z; Jiang H; Cao Y
    Int Immunopharmacol; 2023 Aug; 121():110421. PubMed ID: 37302364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider.
    Rodríguez-Carrio J; Burska A; Conaghan PG; Dik WA; Biesen R; Eloranta ML; Cavalli G; Visser M; Boumpas DT; Bertsias G; Wahren-Herlenius M; Rehwinkel J; Frémond ML; Crow MK; Ronnblom L; Vital E; Versnel M
    RMD Open; 2023 Mar; 9(1):. PubMed ID: 36882218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncoupling interferons and the interferon signature explain clinical and transcriptional subsets in SLE.
    Gómez-Bañuelos E; Goldman DW; Andrade V; Darrah E; Petri M; Andrade F
    medRxiv; 2023 Aug; ():. PubMed ID: 37693590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interferon gene signature as a clinically relevant biomarker in autoimmune rheumatic disease.
    Cooles FAH; Isaacs JD
    Lancet Rheumatol; 2022 Jan; 4(1):e61-e72. PubMed ID: 38288732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon and autoantigens: intersection in autoimmunity.
    Antiochos B; Casciola-Rosen L
    Front Med (Lausanne); 2023; 10():1165225. PubMed ID: 37228405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmunity: twenty years in the Fas lane.
    Ramaswamy M; Siegel RM
    J Immunol; 2012 Dec; 189(11):5097-100. PubMed ID: 23169861
    [No Abstract]   [Full Text] [Related]  

  • 15. The pathogenic role of innate lymphoid cells in autoimmune-related and inflammatory skin diseases.
    Zhou S; Li Q; Wu H; Lu Q
    Cell Mol Immunol; 2020 Apr; 17(4):335-346. PubMed ID: 32203190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dichotomous Regulation of Acquired Immunity by Innate Lymphoid Cells.
    Ebihara T
    Cells; 2020 May; 9(5):. PubMed ID: 32403291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of circulating innate lymphoid cell progenitors results in impaired cytokine production by innate lymphoid cells in patients with lupus nephritis.
    Ryu S; Lee EY; Kim DK; Kim YS; Chung DH; Kim JH; Lee H; Kim HY
    Arthritis Res Ther; 2020 Mar; 22(1):63. PubMed ID: 32223753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCR6+ group 3 innate lymphoid cells accumulate in inflamed joints in rheumatoid arthritis and produce Th17 cytokines.
    Takaki-Kuwahara A; Arinobu Y; Miyawaki K; Yamada H; Tsuzuki H; Irino K; Ayano M; Kimoto Y; Mitoma H; Akahoshi M; Tsukamoto H; Horiuchi T; Niiro H; Akashi K
    Arthritis Res Ther; 2019 Aug; 21(1):198. PubMed ID: 31470891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MICa/b-dependent activation of natural killer cells by CD64
    Sánchez-Cerrillo I; Calzada-Fraile D; Triguero-Martínez A; Calvet-Mirabent M; Popova O; Delgado-Arévalo C; Valdivia-Mazeyra M; Ramírez-Huesca M; de Luis EV; Benguría A; Aceña-Gonzalo T; Moreno-Vellisca R; de Llano MA; de la Fuente H; Tsukalov I; Delgado-Wicke P; Fernández-Ruiz E; Roy-Vallejo E; Tejedor-Lázaro R; Ramiro A; Iborra S; Sánchez-Madrid F; Dopazo A; Álvaro IG; Castañeda S; Martin-Gayo E
    EMBO J; 2023 Dec; 42(23):e113714. PubMed ID: 37916875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Group 3 Innate Lymphoid Cells Exacerbate Lupus Nephritis by Promoting B Cell Activation in Kidney Ectopic Lymphoid Structures.
    Li F; Liang Z; Zhong H; Hu X; Tang Z; Zhu C; Shen J; Han X; Lin R; Zheng R; Tang R; Peng H; Zheng X; Mo C; Chen P; Wang X; Wen Q; Li J; Xia X; Ye H; Qiu Y; Yu J; Fu D; Liu J; Wang R; Xie H; Guo Y; Li X; Fan J; Liu Q; Mao H; Chen W; Zhou Y
    Adv Sci (Weinh); 2023 Dec; 10(35):e2302804. PubMed ID: 37915129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.